Viewing Study NCT00721266


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-01 @ 12:15 PM
Study NCT ID: NCT00721266
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2008-07-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module